Frontline wormer for cats contains praziquantel and pyrantel embonate, and for dogs it also contains febantel.
According to the company, Frontline Wormer is effective agains all types of intestinal worms found in the UK: roundworms, tapeworms, hookworms and whipworms.
It is presented as a palatable tablet which can be given as a treat without food, or mixed with food.
The press release from the company says the new product "gives pet parents an easy way to worm their cats and dogs".
"Pet parents?"
Someone please pass me the sick bag.
If I get one more press release describing cat or dog owners as 'pet parents", so help me god I will turn up at the press office and chain myself - naked - to the photocopying machine in protest.
It's a ghastly, patronising, cloying way to refer to people who own an animal, besides which, if I really was the parent of a pet, I would expect to be serving time at His Majesty's pleasure.
Frontline Wormer is available in packs of two tablets for 3 pet sizes.
As an AVM-GSL-licensed product, it can be sold off the shelf.
238 veterinary surgeons responded to the survey which found that 52.3% of practices reported that they do not have all the veterinary surgeons they need, with the average shortfall being 21.6% or approximately 1/5th of the workforce.
28% reported that this lack of vets meant that they are unable to cover their OOH without unacceptable levels of overtime.
88% of practices had tried to recruit in the past 12 months, 31% of which had failed to find a candidate at the time of the survey.
SPVS carried out a similar survey in 2015 and a comparison between the two showed a worsening situation with only 22% of practices finding a new recruit within three months compared to over 30% two years ago. 90% of respondents also felt the recruitment situation had worsened since four years ago.
An unwillingness to do OOH and dissatisfaction with working hours was cited as the most common reason for candidates not accepting a position, mirroring the results of a survey carried out by VetSurgeon Jobs in 2016. This, combined with most respondents saying that personally they planned to reduce their working hours suggests that the crisis can only deepen and that to succeed in recruitment, employers will have to consider more flexible working.
Brian Faulkner, SPVS President said: "This survey provides valuable evidence to support the profession as they work with government and the colleges to try and counter this crisis in recruitment which threatens to get worse with Brexit. If not tackled it will become increasingly difficult for vets to provide a satisfactory 24 hour health service for the UK’s pets, horses and farm animals."
VetSurgeon.org Editor, Arlo Guthrie said: "This is precisely why recruitment adverts on VetSurgeon.org Jobs run for two months rather than the one month typically offered on other websites. In these difficult times, it is also important to try and use every trick in the book to spread the word about your job, and present it in a way that really stands out. On that score, we're working on some new features designed to help good employers stand out from the crowd. Watch this space."
The full survey is available on the SPVS website at: www.spvs.org.uk
Dr Neil Bryant from the AHT, who is leading the research, said: "EHV is a major welfare concern for horses and foals and causes emotional, as well as financial strains, on horse owners and breeders around the world. It can strike any horse at any time so a vaccine will be of global welfare benefit to all horses, including the thoroughbred and sports horse breeding industries, and would help control this serious and sometimes fatal disease."
As a viral infection, EHV can cause respiratory disease, abortion or fatal illness in new born foals and neurological disease in adult horses, with signs ranging from slight wobbliness through to complete paralysis. The disease can strike any horse at any time because the virus, like other herpesviruses (such as the cold sore virus in humans), becomes dormant within most horses early in their life. It then re-emerges when the animal is later stressed such as when transported or mixed with new horses. A seemingly healthy pregnant mare may suddenly, and without warning, abort her unborn foal or may show signs of respiratory disease including mild fever, coughing and discharge from the nose. A horse which appears fit and well may suddenly show abnormalities when walking and within hours may be unable to stand.
Despite the potential severity and impact of outbreaks, there is still no vaccine that is licensed to protect against the neurological form of the disease and abortions still occur in highly vaccinated horse populations. The AHT says protection afforded by existing vaccines currently in use is sub-optimal, something that was highlighted by the 2016 abortion storm in Hertfordshire in fully vaccinated animals.
Neil added: "We have become aware of a pressing need for progress towards a new and improved EHV-1 vaccine. Just last month, the AHT was again called upon to work with the racing industry and affected parties in dealing with confirmed cases of EHV-1 abortion in premises in Yorkshire and Suffolk."
To that end, the charity has now established the Equine Industries EHV Vaccine Steering Group. Chaired by Professor Joe Brownlie of the RVC, the steering group includes world-renowned experts on both human and equine herpes viruses from a number of research establishments, who have concluded that the most appropriate way forward is for the AHT to design a modified live virus (MLV) vaccine.
After securing funding from a large number of organisations, including the Alborada Trust, EBM Charitable Trust, Horserace Betting Levy Board and the Racing Foundation, Paul Mellon Estate, Thompson Family Charitable Trust, Coolmore Ireland, Newsells Park Stud, Thoroughbred Breeders’ Association and Juddmonte Farms, the AHT has begun its five-year research programme.
Neil added: "We’re at the beginning of a very exciting and potentially ground-breaking vaccine development. Through our research, we will construct different viruses with attenuating mutations and assess their suitability as MLVs. We hope our findings will enable further development by vaccine manufacturers in creating an effective vaccine to protect against the serious clinical signs induced by EHV-1."
The plans developed by the Animal and Plant Health Agency (APHA), an agency of the Department for Environment, Food & Rural Affairs (DEFRA), involved the creation of a new role of Certification Support Officers (CSOs), non-veterinarians who would support the work of Official Veterinarians (OVs) in the signing of export health certificates for products of animal origin such as meat, dairy, processed products and animal by-products.
The proposals for the creation of CSOs by APHA has arisen due to concerns about the growth of exports in recent years and the potential for an up to 300% increase in products requiring OV certification if the UK has to certify exports of products of animal origin to the EU once the UK leaves the EU. Under APHA’s plans CSOs will work under the direction of veterinary surgeons and support their certification work (for example, verifying temperature checks), although the final certification will always need to be signed by OVs. The role will not involve certification relating to live animals or germinal products.
At the RCVS Council meeting on Thursday 1 November 2018 Council members agreed to facilitate APHA’s proposals and to make changes to the RCVS requirements so as to allow CSOs to support OVs in their certification work.
Amanda Boag, RCVS President, said: "As we have stated in our recent statement on ‘no-deal’ Brexit, it has been estimated that there would be 325% increase in veterinary certification requirements if the UK leaves the EU without a deal, and with these proposals Defra and APHA are preparing for this by increasing the support available for Official Veterinarians. Furthermore the proposal is in line with the concept of a vet-led team, with veterinary surgeons focusing on tasks only vets can do, whilst delegating some tasks to suitably trained and quality-assured members of our teams.
"We appreciate that there were some concerns over the level of education and training required by CSOs and are glad that the APHA has accommodated those views by increasing the level of education to three A-Levels (or equivalent in Scotland) and clarifying the nature of the training required by CSOs.
"By signalling its support for the proposals, RCVS Council has been assured that the integrity and value of the veterinary signature will be upheld and we are glad that we can play a key role in helping the veterinary profession prepare the UK for leaving the EU."
The RCVS position statement on the potential impact of a ‘no-deal’ Brexit scenario is available at www.rcvs.org.uk/brexit
Felpreva contains emodepside and praziquantel, with tigolaner, a novel bispyrazole active ingredient.
Felpreva is licensed for treatment of cats with, or at risk from, mixed parasitic infestations/infections.
Vetoquinol points to a survey revealed conducted last year in which 43% of cat owners said that giving parasite protection to their cat makes them feel guilty, stressed, or worried1.
Felpreva provides an option to reduce the frequency of treatments, lessening stressful interactions between owners and their cats.
Vetoquinol says that with Felpreva’s convenience and longer-lasting flea and tick protection, it aims to help support compliance and thus improve the wellbeing of feline companions.
Helen Hunter, Senior Product Manager at Vetoquinol UK, said: “The launch of Felpreva is a truly proud moment for Vetoquinol, demonstrating our expertise, passion, and commitment to innovation in this essential category of companion animal medicine.
"It will allow us to safeguard the health of cats by bringing longer-lasting protection, convenience, and ease of use – for both pet owners and veterinary professionals.
"At a time when vets are treating more pets than ever before, the need for a breakthrough endectocide solution like Felpreva has never been greater.”
Felpreva is in wholesalers now.
For more information, contact your local Vetoquinol representative.
Reference
To take part in the survey, which will take about ten minutes, visit: https://www.surveymonkey.co.uk/r/RepRIPorVIP.
Everyone who completes the survey will be entered into a draw to win one of three £50 Amazon vouchers.
The House of Lords debate, which is being hosted by Professor The Lord Tress of Kinross, will take place on Wednesday, 21st June 2023.
Speakers will include Donal Murphy of NOAH, Rita Dingwall of the Federation f Independent Veterinary Practices and Paul Horwood, Country Head of Farm at IVC Evidensia.
https://vma.org.uk/house-of-lords/
The current strain of bluetongue emerged in the Netherlands in 2023 and spread rapidly, infecting over 5,000 livestock farms.
Infection of livestock with this serotype of the virus can result in severe clinical signs and high mortality rates1, significantly impacting animal health, and farming communities.
Bultavo 3 is an inactivated injectable vaccine indicated for the active immunisation against BTV-3.
Boehringer says that in sheep, Bultavo 3 has been shown to significantly reduce viraemia and prevent mortality and clinical signs associated with BTV-3 infection.
Onset of immunity occurs three weeks after administration of a single 1ml subcutaneous dose in sheep.
In cattle, two 1ml intramuscular doses are required, at a three-week interval.
Findlay MacBean, Head of Livestock, UK and Ireland at Boehringer Ingelheim, said: “It’s great news that we can support farmers and authorities in their fight against bluetongue with our new BTV-3 vaccine, Bultavo 3.
"As we have seen across Europe, and now in the UK, BTV can spread rapidly and causes considerable stress to farmers because of the significant financial impact on those affected.
The availability of Bultavo 3 means future BTV-3 outbreaks can be suppressed, helping farmers protect not only their herds, but also their livelihoods.” Oli Maxwell, BVSc BSc(Hons) MVM DipECBHM, RCVS Recognised Specialist in Cattle Health and Production and Clinical Director of Green Counties Vets said: “Farmers are justifiably concerned about BTV-3 and its incursion into the UK again this year.
"Reports from colleagues on the continent regarding the severity of clinical signs, especially in sheep are worrying.
"We have seen a huge increase in clients asking about the disease, progress on a vaccine and what this may mean for animal movements at a critical time of year.
"The availability of a safe and effective vaccine as a critical tool against a disease that we can’t reasonably prevent with biosecurity measures will be a welcome development for many.”
To manage supply and demand, use of the product will initially be subject to geographical restriction with vaccination permitted in high-risk English counties: Norfolk, Suffolk, Essex, Kent and East Sussex.
Reference:
Merial has launched Supleneo flex, a nutraceutical supplement designed to be part of a Total Joint Health programme for dogs, administered once daily.
Merial says the new product supports its market position as a leading force in canine pain management, supported by the canine NSAID Previcox.
According to the company, Supleneo flex is suitable for all breeds, sizes and ages, and contains three key ingredients associated with joint health: glucosamine hydrochloride, chondroitin sulphate and mixed tocopherols (Vitamin E). It is designed to be used as part of an all-round joint care programme, alongside nutrition, weight management and exercise.
Merial says the soft chews are highly palatable and when tested against a range of competitor products, a significant difference was observed, with Supleneo flex readily taken and preferred by dogs.1
Supleneo flex is supported by printed and digital materials to help with owner education, including a waiting room video and an online information website at www.supleneoflex.co.uk for clients.
For veterinary surgeons, Merial is offering product advertising support and a loyalty programme.
For more information, telephone Merial on 0870 6000 123 or contact your Territory Manager.
VetSurgeon.org has announced the launch of VetSurgeon Jobs, a new service designed to change the way veterinary surgeons are hired, saving veterinary practices hundreds, sometimes thousands of pounds.
Since 1761, when the veterinary profession first came into existence, employers have had no choice but to advertise job opportunities for veterinary surgeons and practice managers in magazines.
Editing, printing and publishing a magazine is an eye-wateringly expensive business, costs which have been reflected in the price advertisers have had to pay.
The Internet has brought those costs right down. Furthermore, in a survey of job seekers carried out last earlier this month by VetSurgeon.org, 70% said they spend most time browsing jobs online these days, as opposed to in a magazine.
However, when you look at the costs of advertising on websites published by veterinary magazine publishers, which start at £395 and quickly rise to £795 for a 28-day online advert, it is clear that these prices still reflect the considerable costs of magazine production.
Today, VetSurgeon.org launches it’s online-only job advertising service, priced simply at £99+VAT, which gets you a 60-day advert on the website most followed by UK veterinary surgeons.
That price doesn’t just offer a considerable saving over alternatives in the veterinary profession, it also beats the major online-only players outside the profession (including Monster, Reed and Totaljobs)
There’s more to it than just price, though. Unlike the alternatives, VetSurgeon Jobs is not an 'off-the-shelf' solution, but something designed from the ground up for the veterinary profession.
For jobseekers, VetSurgeon Jobs has been designed to make finding the right job as simple and straightforward as possible. Just enter the postcode and search radius, and the available jobs re-order by distance. You can subscribe to be alerted of only those jobs that meet your very specific criteria (such as locum positions within a given radius). Perhaps most importantly, VetSurgeon Jobs is an integral part of the thriving community on VetSurgeon.org. So you can add your CV to your online profile and then engage directly with employers on the site.
For employers, VetSurgeon offers the opportunity to publish a more engaging, interesting advertisement than is currently offered anywhere else, including maps, photos, logos and headline propositions.
Arlo Guthrie said: "It’s a cliche, but if ever there was a 'win-win' situation, this is it. I’m able to offer you the chance to save a small fortune, whilst making some for myself and to reinvest in yet more features designed to support your profession."
For more information, visit https://www.vetsurgeon.org/jobs/, ring 0207 183 2511 or email support@vetsurgeon.org.
And if you want to support our efforts ... please share this story using the links immediately below.
The RCVS has launched a new College honour, the RCVS Queen's Medal.
RCVS President Col Neil Smith said: "The Queen's Medal will be the most prestigious honour that the RCVS can bestow upon a veterinary surgeon and will be reserved for those whose distinguished careers and outstanding lifetime achievements deserve wider recognition."
The honour was created following a review of the RCVS honours system, which demonstrated the need for a new aspirational award.
The RCVS wrote to the Cabinet Office last year, together with letters of support from Peers and MPs, many of whom attended the reception, to request permission to name this new honour after Her Majesty the Queen.
Col Smith said: "We are honoured that Her Majesty has supported the proposal and allowed the College to name the award after her, and express our sincere thanks to those Parliamentarians who supported our endeavour."
The first RCVS Queen's Medal will be presented at RCVS Day in July 2014. The nomination form for the Queen's Medal can be found at www.rcvs.org.uk/Queensmedal.
The publishers say that many people who prescribe veterinary medicines or who handle them (or bodily fluids that may contain them or their active metabolites) are not aware of the potential harmful effects they can have on human reproduction.
'Handling Veterinary Medicines and Pregnancy' gives up-to-date, evidence-based guidance on which drugs and methods of handling are hazardous; information on the relevant regulations relating to the safe handling of such medicines; and practical guidance on avoiding harm in veterinary practice.
Veterinary Prescriber says that once you have completed the module, you will:
understand the principles of reproductive toxicity
understand how data on the harmful effects of medicines are generated
be aware of the evidence on reproductive harm in veterinary practice
understand what practical measures to take to avoid harm
know where to find helpful information on medicines and pregnancy
For more information, visit: https://www.veterinaryprescriber.org/subscribers/
Dr Pete Down, Associate Dean for Undergraduate Education in UCLan’s School of Veterinary Medicine, said: “We recognise the multifaceted challenges the profession is facing at the moment, but many of us have spent significant time out in practice and recognise that it can be a fantastic career.
“Additionally, first-opinion vets provide essential services to the pet-owning public, equine, and farming industries.
"Our curriculum focusses on the provision of contextual-care and encourages vet students to see general practice as a fantastic career in and of itself.
"Also, whilst diversity in the profession has traditionally been a challenge, our student recruitment practices support an inclusive approach, recruiting students from a wide variety of backgrounds.”
The practically focused curriculum is ‘hands-on’ from year one and the university says it uses innovative digital technologies from the outset: its students will be among the first in the country to use specialist Anatomage vet tables.
Dr Heather Bacon OBE, Dean of UCLan’s School of Veterinary Medicine, said: “It’s a landmark day for the University as we’ve welcomed our first cohort of veterinary medicine students through the door.
"The demand for places on the first year of our BVMS course was huge and I’m thrilled we’ve been able to enrol so many enthusiastic student vets on to our programme.”
https://www.uclan.ac.uk/undergraduate/courses/veterinary-medicine-surgery-bvms
Omniotic combines three ingredients to remove ear wax and debris: a detergent, a solvent and an emulsifier. It also contains Octoxynol-9, lactic acid, salicylic acid and parabens, which Vita says have anti-fungal, anti-viral and anti-bacterial properties.
The product is sold in 120ml bottles with a transparent flexible tip designed to be comfortable even in stenosed, tender ear canals.
Omniotic can be used for regular daily cleaning, especially in predisposed breeds such as spaniels and lop-eared rabbits where ear conformation increases the risk of ear disease.
The product can also be used alongside other antibiotics or anti-fungal medications, something which Vita highlights as being especially important in rabbits, the ear canals of which are less prone to inflammation and stenosis, and for which topical treatment can be very effective.
Tara Evans, RVN and sales manager said: "Omniotic is an ear cleaner for dogs, cats and rabbits which combines features to meet the needs of owners and vets at the same time. The feedback from our customers is very positive; they are finding the soft, flexible applicator tip is easy to use and well tolerated. The unique combination of ingredients and the multi-species use means Omniotic can be used to support ear health across a wide variety of indications."
For more information and for the latest promotional offers, contact Tara Evans, via email: info@vitaanimalhealth.com, or telephone: 01256 591032.
Xperior Farm Health, one of the bidders for the government contracts to provide TB testing, has announced that it mounted a legal challenge to the procurement process, but has now withdrawn that challenge in the face of the 'aggressive' timeframe in which Defra demanded that it submit its case.
Xperior says it was made aware last month that all five Delivery Partner contracts would be awarded to members of the same veterinary group (XL Vets), which it felt would both compromise competition and make Defra overly reliant on one service provider.
In addition, Xperior said it believed the successful bids were unfeasibly low, which presents a potentially devastating threat to the viability of many rural vet practices and a seriously reduced quality of TB testing service to farmers.
Xperior says it initially notified a formal query to the Animal and Plant Health Agency (APHA - the executive agency of Defra responsible for awarding the contracts) during the pre-announcement consultation period, and believes other bidders may have done likewise. The query was dismissed, as a result of which the company issued legal proceedings.
Xperior's Veterinary Director, Phil Elkins said: "We are concerned that proposed payment rates for TB testing are considerably lower than those proposed by other bidders, and at a level which questions the viability of practices continuing to provide TB testing services to their clients.
"The consequence would be either unfairly low payment rates for official veterinarians (OVs) who conduct TB testing, or an influx of inexperienced vets, potentially from other countries, into low paid positions. The loss of TB testing income would also challenge the viability of some rural veterinary businesses and the relationships held with their clients.
"Either way, this is contrary to a key tenet in the pre-tender documentation that Delivery Partners are expected to maintain a flow of TB testing work and revenue to contribute to the capability of the veterinary profession in rural areas to support food security and the rural economy."
Meanwhile, an APHA spokesperson said they were limited in how much they could say before the formal announcement of the award, except that: “APHA is confident in the robustness of the procurement process and that the selected bidders are the best candidates to deliver this vital service in the most effective way.”
VetSurgeon.org understands that now the legal challenge has been dropped, an official announcement of the winner will likely be made within days. However, it also seems likely that the payment rates for OVs will remain confidential even after the announcement of the award, so it may be some time before the prospects for OVs become clear.
SPVS/VPMA Congress, which is supported by Boehringer and Citation, will be opened this year by Benjamin Mee, motivational speaker, journalist and the man behind the bestselling book and Hollywood blockbuster "We Bought A Zoo".
Other highlights in the CPD programme include:
The exhibition offers a range of suppliers with advice on marketing, management and business development.
For this year’s President's banquet the theme will be a touch of Moulin Rouge, with high energy festival and party band, RPJ, headed by Rick Parfitt Jnr. Congress will start on Thursday with a Congress Cabaret night, featuring Edinburgh Fringe regulars, Peablossom Academy.
To register and for full details of the programme and sponsors, visit www.spvs-vpma-events.co.uk
The app allows trainers to store and share medical records and treatment plans, identify horses and, with a Bio Thermo chip, monitor temperature non-invasively.
In Ireland, the Irish Horse Racing Board (IHRB) requires every yard keep a Blue Book which has to be submitted monthly. In the Blue Book, every medication given to every horse is recorded, with the amounts, the name of the medication and its batch number all written in by hand. EquiTrace enables a trainer to email the blue book information direct from their mobile phone.
Vincent O’Connor, senior vet at Sycamore Lodge Equine Hospital on the Curragh, Ireland, says he has found the app very easy to use and particularly appreciates the way it suggests stand down periods required for intraarticular medication, where injections into different joints require different numbers of days withdrawal before competition. The experience of John Oxx, whose winner I Know I Can was disqualified because of a positive test for TCA (triamcinolone acetonide) on 2 July 2020, is a case in point. Dr Lynn Hillyer, IHRB Chief Veterinary Officer and Head of Anti-Doping, stated that the minimum recommended stand down time for TCA would be 14 days but added that the stifle is a complex joint and can be associated with longer excretion times than might be expected.
Kevin Corley said: "Keeping a horse’s identity straight might seem a simple thing, but when you have a yard where staff and horses can change frequently and records are kept in the office, far away from the stables and fields where the horses are, it is not as easy as you think. I remember a time when I was called out to genetically test four two year olds, each valued at over €50,000 because their registration documents had been lost before they had been filed and no one knew which one was which."
EquiTrace has been in trials in Ireland, England, USA, Sweden and Italy and Kevin says every yard which has tested the app has kept it in operation.
EquiTrace is a subscription service, with a basic service for $1/€1 per month per horse and a premium subscription at $2/€2 per month per horse. A scanner available from EquiTrace as a one-time cost is required to operate the system, ranging in price from €250 to €400 or USA $350 to $550.
EquiTrace works with all ISO-compliant microchips but some of the service offerings are dependent on the type of chip in the horse.
EquiTrace is available on Apple and Google appstores. Establishments with over 200 horses can contact EquiTrace directly to arrange a subscription. Current clients include DK Weld in Ireland, Ramsey Farm and Three Chimneys Farm in Kentucky, USA, Kinsale Stud in the UK and Avantea in Italy.
For more information, visit: https://equitrace.app
Brian (pictured right), said: “I am absolutely delighted that Colourful CPD has joined Agilio and I see this as a win-win-win for Colourful CPD, Agilio and the veterinary profession.
"Colourful CPD’s courses complement Agilio’s vast array of existing statutory and mandatory courses which they already distribute within the UK as well as all around the world, thus enabling Colourful CPD to make the move up to the next level, both here and abroad.
I believe veterinary practices, as well as all the roles working within them, will benefit from being able to access a range of new courses and management services from Agilio.”
To mark its expansion into the veterinary sector, Agilio will be launching iTeam, its HR and rota software, together with iLearn, an online training and CPD accredited platform at the London Vet Show in November.
https://www.colourfulcpd.comhttps://agiliosoftware.com
Ceva Animal Health has launched a new broad-spectrum, flavoured endoparasiticide tablet, Milbactor for dogs.
Milbactor contains milbemycin oxime and praziquantel, which offer protection against the common nematodes seen in the UK and the main species of tapeworm.
Milbemycin oxime treats Toxocara canis and Toxascaris leonina, Angiostrongylus vasorum and Crenosoma vulpis, the hookworm Ancylostoma caninum, the whipworm Trichuris vulpis and the eyeworm, Thelazia callipaeda. Milbactor also prevents heartworm disease caused by Dirofilaria immitis.
Praziquantel protects against Echinococcus spp., Dipylidium caninum, Taenia spp. and Mesocestoides spp.
Puppies weighing more than 0.5 kg can be treated with Milbactor from two weeks of age. Milbactor comes in two tablet sizes for dogs and puppies, and the tablets are flavoured for easy administration.
Ceva has also launched The Ceva Protection System for dogs, a two-step solution featuring Vectra 3D and Milbactor to provide ectoparasite and endoparasite protection for dogs with one monthly topical treatment and one flavoured tablet. The Ceva Protection System uses Vectra Felis for flea protection for cats and Acclaim for the treatment of the pet's home environment.
Rob McLintock MRCVS, companion animal business unit manager at Ceva Animal Health, said: "The launch of Milbactor and The Ceva Protection System will enable veterinary surgeons to offer their clients a simple regime featuring Vectra 3D and Milbactor for comprehensive parasite control in dogs. Offering protection both inside and out and with no bite required to kill fleas, the regime offers a simple, effective combination to treat and prevent fleas, ticks, biting flies, roundworms, tapeworms, lungworms and to prevent heartworm.
For further information on The Ceva Protection System, Milbactor, Vectra 3D or Vectra Felis, contact your local Ceva territory manager or call 01494 781510.
"We would like to reassure vets, and through them dog owners, that we are constantly reviewing adverse event report data to ensure that the benefits of each UK licenced veterinary medicine product outweighs the risk posed by their potential side-effects.
There are a number of vaccines authorised in the UK containing either two (L2) or four (L4) strains of Leptospira. Based on the most recent periodic safety update report data received for each product, the incidence of adverse animal reactions for all L2 vaccine products combined is 0.015%; for L4 vaccine products this figure is 0.069%.
In other words, the VMD has received fewer than 2 adverse reactions for L2, and fewer than 7 for L4, for every 10,000 doses sold. This includes every suspected adverse event reported, even cases that were considered unclassifiable or were later found to be unrelated to the vaccine.
The overall incidence of suspected adverse reactions for both L2 and L4 vaccine products is therefore considered to be rare."
The new product contains astaxanthin (an anti-oxidant), fucoidan (a fucose-rich, sulfated polysaccharide) and indigo (a deodorant), which together are claimed to fight against gum infections, deodorise the mouth, and reduce the build-up of plaque and tartar.
Bob Ferguson, Commercial Lead for Accord Animal Health said: “We are excited to bring to the UK and Ireland market, Vivinicord Chews, a novel combination of natural ingredients designed to aid pet owners support their dogs’ oral health.
"Dental disease and associated infections are such a huge issue for vets and owners, we believe Vivinicord Chews can be a valuable part of the solution.
“Vivinicord Chews will only be available for owners to buy from their local veterinary practice, supporting our mission of building a sustainable partnership with our veterinary customers.”
Vivinicord comes in packs of 30 chews with a shelf life of 24 months.
For further info or stock enquiries, contact: info@accord-animalhealth.com / 01271 385 200
Otomicol contains miconazole nitrate, prednisolone acetate and polymyxin B.
The product targets a range of pathogens including miconazole and polymyxin B-sensitive, Malassezia and Pseudomonas spp.
Renzo Di Florio, technical vet at Krka UK, said: “With its multifactorial aetiology, ear disease is often challenging to manage, causing frustration for owners and significant discomfort for pets.
"Otomicol is a cost-effective solution that veterinary surgeons can add to their treatment toolbox for cases where bacterial and fungal infection are important factors.”
Otomicol ear drops and cutaneous suspension are available in a 15ml bottle with an extended shelf life of six months after opening.
Otomicol is available from veterinary wholesalers.
https://www.krka.co.uk
The BVA, the Mayhew Animal Hospital, Dogs Today magazine and the Kennel Club are amongst various organisations that have criticised Morrisons for its Christmas advert - which can be seen here - in which a child is seen passing a slice of Christmas pudding to the family dog.
BVA President Peter Jones said: "It is vital that advertisers use animals responsibly and we are disappointed to see the Morrisons Christmas desserts TV commercial depicting a small boy feeding Christmas pudding to his dog. Christmas pudding, Christmas cake and mince pies - because they contain raisins or sultanas - are potentially harmful to pets and in some cases can lead to kidney failure.
"While we accept that many pet owners understand what is and what is not appropriate to feed their pets, children watch adverts and can be easily influenced by what they see. Veterinary organisations and animal welfare charities work really hard to promote messages about responsible pet ownership and TV adverts such as this one, with huge audiences, can undermine this work."
But hang on a second. Watching the advert, the child isn't actually feeding the dog anything. Rather, the dog is passed a bit of pudding which it then goes and places in a flowerpot, causing the plant to wilt. The dog isn't being fed the stuff, it's being asked to get rid of it.
Surely what this advert is really saying is: nobody likes Christmas pudding, least of all children and dogs.
Mind you, it does look like all this fuss is proving a very effective public awareness campaign about the danger of feeding a dog raisins or sultanas.
Having been told at school that he'd never cut it as a veterinary surgeon, Julian qualified from Liverpool in 1981. He became a partner at Banovallum Vets in Horncastle in 1989 and later the sole owner. Along the way, he also gained AP status in Sheep and Animal Welfare and served as President of the Sheep Veterinary Society and the Lincolnshire Veterinary Association. Oh, and in 1991, he was part of a team that set a world record relay time cycling from Land's End to John O'Groats, raising £8,500 in the process.
Then, in 2012, everything changed. Julian had a cycling accident during a road race in Lincolnshire. He fractured his skull and suffered multiple brain haemorrhages, broken ribs, a fractured shoulder and a punctured lung. Doctors told his wife he'd be unlikely to survive.
But survive he did, and with his injuries precluding a return to practice, he's reinvented himself as an author and approved para-cyclist.
His book is a collection of light-hearted anecdotes and memories from his life in practice, with practical advice about what to try and avoid when working as a veterinary surgeon.
And yes, he was once called out to attend a cow stuck in a tree!
You can buy the book on Amazon in hardcover for £12.95, here: http://www.amazon.co.uk/Julian-Earl/e/B01EVCT67K/ref=sr_ntt_srch_lnk_1?qid=1461874827&sr=1-1
The new product contains a combination of Omega-3s, toxin binders and antioxidants which the company claims flush out toxins, aid blood flow to the kidneys and maintain kidney architecture.
Matthew Shaw, Managing Director of nutravet said: "We’re really excited to launch nutraren, it’s a product our team have been working on for some time to make sure we have developed the best renal product for vets to recommend to their clients.
"Using independent trial data, we’ve been able to develop a unique formulation for nutraren containing 100% natural ingredients to benefit a pet’s long-term kidney health."
Authorised veterinary practices can now order nutraren from nutravet.
For more information, contact nutravet on 0845 604 1688, visit: www.nutravet.co.uk or email: info@nutravet.co.uk.
The BVA is also calling on Government to tighten pet import rules.
The advice follows news about a positive Brucella canis test in a rescue dog imported from Belarus in March this year.
The woman fostering the dog was hospitalised after coming into close contact with it, in the UK’s first confirmed dog-to-human transmission.
The foster animal and four pet dogs who were exposed to the disease, three of whom also tested positive, all had to be euthanised.
Data released by the Government shows a steep rise in confirmed Brucella canis cases since the start of 2020, rising from just three before that year to 107 till July this year.
The dogs were all either imported, had returned from holiday overseas, or been bred with an imported dog.
BVA is asking veterinary teams to:
British Veterinary Association President Justine Shotton said: “This recent case of Brucella canis in a foster dog is extremely tragic and highlights why vets have long raised concerns over the real and serious risks of importing ‘Trojan’ rescue dogs with unknown health histories into the UK.
“We know there is an added public health risk too, including for veterinary teams who treat and handle these animals, from contact with an infected dog’s contaminated body tissues and fluids.
"BVA continues to call on the Government to take urgent action to introduce stricter pet import measures, including mandatory pre-import testing, so we can minimise the spread of Brucella canis and other emerging diseases.
"We are also calling for the strengthening of enforcement provisions and checks on dogs brought into the country through the commercial route."
The 2021 B. canis risk view and statement by Public Health England (now UK Health Security Agency) contains vital information and recommendations for veterinary professionals: here:https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/960013/20210210_Brucella_canis_statement.pdf
BVA’s recommendations on tightening pet travel legislation: https://www.bva.co.uk/uploadedFiles/Content/News,_campaigns_and_policies/Policies/Companion_animals/BVA%20Position%20on%20Pet%20Travel%20Full.pdf